Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

Zscaler posted better-than-expected earnings and sales results for its second quarter on Thursday. The company said it expects fiscal year 2024 non-GAAP income from operations between $395 million and $400 million and net income per share between $2.73 and $2.77.

Zscaler shares fell 10.1% to $217.43 on Friday.

Here are some other stocks moving in today's mid-day session.

Gainers

• BioVie Inc. (NASDAQ: BIVI) shares climbed 96.1% to $2.4319. BioVie's Ne3107 demonstrated potential improvements in motor and non-motor symptoms for Parkinson's disease patients and may be realigning physiological processes for Alzheimer's patients.
• Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 68.4% to $3.4350. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder.
• Cardiff Oncology, Inc. (NASDAQ: CRDF) shares rose 41.5% to $2.50 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.
• Minim, Inc. (NASDAQ: MINM) shares rose 41.4% to $6.09. On Feb. 20, Minim entered into an employment agreement with David Lazar to engage him as CEO, CFO, following resignation of Jeremy Hitchcock.
• The RealReal, Inc. (NASDAQ: REAL) gained 39.1% to $2.4613 following upbeat quarterly results.
• Nxu, Inc. (NASDAQ: NXU) shares gained 36.4% to $1.09 after the company announced it successfully charged a Tesla Cybertruck on Feb. 26.
• Jaguar Health, Inc. (NASDAQ: JAGX) climbed 35.3% to $0.0798.
• Dell Technologies Inc. (NYSE: DELL) rose 26.3% to $119.52 as the company reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%.
• Sweetgreen, Inc. (NYSE: SG) gained 26% to $16.05 after the company reported better-than-expected fourth-quarter financial results.
• MMTec, Inc. (NASDAQ: MTC) climbed 25% to $1.61.
• Everbridge, Inc. (NASDAQ: EVBG) rose 24.5% to $35.19 after it amended and restated the previously announced merger agreement with Thoma Bravo.
• NetApp, Inc. (NASDAQ: NTAP) shares gained 24.4% to $110.85 after the company reported better-than-expected third-quarter financial results and issued guidance.
• Xponential Fitness, Inc. (NYSE: XPOF) climbed 24% to $12.50 following strong quarterly sales.
• Myomo, Inc. (NYSE: MYO) gained 21.9% to $3.73.
• Ventyx Biosciences, Inc. (NASDAQ: VTYX) climbed 20.1% to $8.50.
• MSP Recovery, Inc. (NASDAQ: LIFW) gained 18.8% to $1.01.
• Opera Limited (NASDAQ: OPRA) rose 18.8% to $14.47 following strong sales.
• REGENXBIO Inc. (NASDAQ: RGNX) climbed 18.5% to $20.66.
• RadNet, Inc. (NASDAQ: RDNT) gained 18.1% to $44.71 following strong quarterly results.
• Sana Biotechnology, Inc. (NASDAQ: SANA) rose 17.3% to $11.78 after the company reported a year-over-year increase in fourth-quarter financial results.
• Tidewater Inc. (NYSE: TDW) gained 15.3% to $80.73 following fourth-quarter financial results.
• Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) gained 14.3% to $19.09 after the company reported better-than-expected fourth-quarter financial results.
• Repay Holdings Corporation (NASDAQ: RPAY) rose 14.4% to $9.94 following upbeat quarterly results.
• Root, Inc. (NASDAQ: ROOT) gained 14.2% to $36.66. Jefferies analyst Yaron Kinar upgraded Root from Hold to Buy and raised the price target from $10 to $40.
• MasTec, Inc. (NYSE: MTZ) rose 11.2% to $83.89 following strong quarterly results.
• Rambus Inc. (NASDAQ: RMBS) gained 9.3% to $64.76. Rambus initiated accelerated share repurchase program to repurchase an aggregate of $50 million of its common stock.
• Arvinas, Inc. (NASDAQ: ARVN) rose 9.2% to $50.21. Barclays analyst Peter Lawson maintained Arvinas with an Overweight and raised the price target from $26 to $60.
• The Cooper Companies, Inc. (NYSE: COO) gained 7.4% to $100.61 after the company reported better-than-expected first-quarter financial results and raised guidance.

• GigCapital5, Inc. (NASDAQ: GIA) shares fell 60.7% to $4.35. GigCapital5 announced closing date of March 4, 2024 for business combination with QT Imaging.
• Fisker Inc. (NYSE: FSR) shares tumbled 44.6% to $0.4035 after the company reported preliminary fourth-quarter total revenue results below estimates and said it expects to conclude there is substantial doubt about its ability to continue as a going concern when its annual financial statements are filed with the SEC.
• Sidus Space, Inc. (NASDAQ: SIDU) fell 39.9% to $5.41. Sidus Space priced public offering 1,321,000 Class A common share at $6 per share.
• Scilex Holding Company (NASDAQ: SCLX) shares declined 39.7% to $1.37 after reporting a $10 million bought deal offering.
• DermTech, Inc. (NASDAQ: DMTK) fell 32.8% to $0.86 after the company reported worse-than-expected quarterly revenue results.
• Precision BioSciences, Inc. (NASDAQ: DTIL) fell 31.7% to $12.62 after the company announced a $40 million offering of common stock and warrants.
• Volcon, Inc. (NASDAQ: VLCN) fell 30.1% to $0.93.
• Tritium DCFC Limited (NASDAQ: DCFC) fell 27.4% to $0.1031.
• Vivani Medical, Inc. (NASDAQ: VANI) declined 27% to $3.0798. Vivani Medical announced pricing of $15 million registered direct offering of common stock and warrants.
• Humacyte, Inc. (NASDAQ: HUMA) shares dipped 25.3% to $3.2450. Humacyte priced its $40.2 million public offering of 13.4 million common stock at $3 per share.
• New York Community Bancorp, Inc. (NASDAQ: NYCB) fell 24.2% to $3.6301 after the company identified material weakness in internal controls and announced a leadership transition.
• JAKKS Pacific, Inc. (NASDAQ: JAKK) fell 23.7% to $26.79 following weak quarterly results.
• TTEC Holdings, Inc. (NASDAQ: TTEC) dipped 22.6% to $13.50 after the company reported mixed fourth-quarter financial results and issued FY24 adjusted EPS and revenue guidance below estimates.
• Gritstone bio, Inc. (NASDAQ: GRTS) fell 20.5% to $2.2250 after the company announced an approximately 40% reduction of its workforce.
• NCR Voyix Corporation (NYSE: VYX) declined 19.8% to $11.72. NCR Voyix said it sees preliminary FY23 revenue of $3.830 billion.
• Cue Health Inc. (NASDAQ: HLTH) shares fell 15.6% to $0.2699. Cue Health has received a decision to grant European patent number EP3191849 titled "Systems and Methods for Detection and Quantification of Analytes."
• P10, Inc. (NYSE: PX) fell 15.2% to $7.86 following fourth-quarter results.
• Elastic N.V. (NYSE: ESTC) shares dipped 14.1% to $114.91 after the company reported third-quarter financial results.
• American Coastal Insurance Corporation (NASDAQ: ACIC) fell 13.1% to $12.11 following weak sales.
• B. Riley Financial, Inc. (NASDAQ: RILY) shares declined 12.5% to $15.96 after the company reported fourth-quarter financial results and announced it has launched a review of strategic alternatives for its Appraisal and Valuation Services, and Retail, Wholesale & Industrial Solutions businesses.
• SoundHound AI, Inc. (NASDAQ: SOUN) shares fell 11.6% to $6.56 after the company reported weaker-than-expected fourth-quarter financial results.
• Senseonics Holdings, Inc. (NASDAQ: SENS) fell 10.1% to $0.6311 following fourth-quarter results.
• Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) fell 9.7% to $1.3715 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 revenue guidance below estimates.
• Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) fell 9.5% to $1.3750 following downbeat quarterly results.
• Xcel Energy Inc. (NASDAQ: XEL) fell 6.4% to $49.29.

Now Read This: Jim Cramer Says This Is A 'Smart Consulting Company,' Calls Commercial Metals Company A Winner

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga